Articles by Anthony J. DeStefano, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Anthony J. DeStefano, PhD

Anthony J. DeStefano, PhD


Anthony J. DeStefano, PhD, is vice-president, general chapters at the United States Pharmacopeial Convention.
Articles
Inside USP: US Pharmacopeia Proposes New Standard on Glass Quality
June 2, 2012
By: Anthony J. DeStefano, PhD , Desmond Hunt

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Inside USP: A Holistic Approach to Supply-Chain Integrity
March 2, 2012
By: Anthony J. DeStefano, PhD , Desmond Hunt

US Pharmacopeia documents best supply-chain practices and seeks broad input on proposal.
Inside USP: Global Harmonization Presents Opportunities and Challenges
January 2, 2012
By: Anthony J. DeStefano, PhD , Kevin Moore

To keep moving forward, the Pharmacopoeial Discussion Group needs industry participation.
Inside USP: Adulteration and Contamination Awareness
November 2, 2010
By: Anthony J. DeStefano, PhD

USP is working to ensure quality standards and to increase public information.
Inside USP: USP Metals Testing: A Workshop Report
November 2, 2008
By: Stefan Schuber, PhD , Anthony J. DeStefano, PhD , Roger L. Williams , William F. Koch , Darrell R. Abernethy

Attendees at a recent workshop endorsed new methods to detect metals in drugs, dietary supplements, and food ingredients.

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
42%
Facility/environment problems
0%
Process development problems
8%
Production equipment downtime
8%
Raw material supply problems
25%
Regulatory restrictions
0%
Business decisions to limit production
17%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here